Back9 Meters Biopharma Overview
9 Meters Biopharma Inc

9 Meters Biopharma Price to Book Ratio

Latest P/B ratio for 9 Meters Biopharma: -0.07 — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Price to Book

-0.07

Price to Book Ratio

-0.07

The Price-to-Book ratio compares a company's market value to its book value. A lower P/B ratio may suggest that the stock is undervalued relative to its assets.

Price to Book (Comparison Companies)

Loading

Price to Book Ratio History

Loading

Price to Book Ratio Comparison

Loading

9 Meters Biopharma (NMTR) FAQ

As of the most recent data, NMTR shows a P/B ratio of -0.07. That is below the Technology sector average of 17.63. Scroll down for historical charts and peer comparison views.

The Technology sector average P/B ratio is about 17.63. 9 Meters Biopharma is at -0.07, which is lower that average. That is roughly 100.4% below the sector mean. Use the comparison chart on this page to see how NMTR stacks up against individual peers as well.

Investors watch NMTR's P/B ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. 9 Meters Biopharma's latest reading is -0.07. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this price-to-book ratio page, Stockcircle has 9 Meters Biopharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/B ratio (currently -0.07) with ownership activity and broader fundamentals.

The Technology average P/B ratio is about 17.63, while NMTR is at -0.07. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.